Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Peptides

Tundra lists 5 Peptides clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07583654

Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors

The goal of this phase 1 clinical trial is to evaluate the safety, tolerability, and preliminary antitumor activity of a peptide-delivered IL-22BP biotherapy in patients with advanced solid tumors. The main questions it aims to answer are: Is the IL-22BP formulation safe and tolerable? Does the IL-22BP formulation show preliminary antitumor activity?

Gender: All

Ages: 18 Years - 70 Years

Updated: 2026-05-13

mRNA Vaccine
Solid Tumor Cancer
Peptides
+1
RECRUITING

NCT07528469

The Effects of PeptiStrong and Whey on Muscle Function In Older Adults

Examining the effects of PeptiStrong and protein on muscle function in older adults

Gender: All

Ages: 60 Years - 85 Years

Updated: 2026-05-06

Healthy Ageing
Protein Supplementation
Muscle Health
+4
NOT YET RECRUITING

NCT07451769

Selective Activation of the Adrenomedullin Receptors in Migraine

Adrenomedullin is a neuropeptide implicated in the pathogenesis of migraine. This study investigates whether its administration, after pre-treatment with erenumab (a CGRP-receptor blocking monoclonal antibody), can trigger migraine attacks in individuals with migraine without aura.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-03-09

Migraine
Brain Diseases
Central Nervous System Diseases
+5
NOT YET RECRUITING

NCT07340788

Amylin-Induced Migraine Attacks Without Aura

Pramlintide is a peptide analogue of human amylin which is a vasoactive signaling molecule involved in the pathogenesis of migraine. This study investigates whether pramlintide induces migraine attacks without aura in people with migraine without aura.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-01-14

Headache Disorders, Primary
Headache Disorders
Brain Diseases
+15
NOT YET RECRUITING

NCT07340775

Hypersensitivity to Amylin in Post-Traumatic Headache

Pramlintide is a peptide analogue of human amylin which is a vasoactive substance involved in the pathogenesis of headache. This study investigates whether pramlintide induces migraine-like headache in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-01-14

Headache Disorders, Secondary
Brain Diseases
Headache Disorders
+14